Replies to post #123602 on Biotech Values

[sodrock]

Which analyst is this re MNTA? Tia

[exwannabe]

We note it has been about 6 months since the FDA minor deficiency letter for TEVA's generic enoxaparin. As additional time passes, we believe approval of TEVA's generic becomes more questionable.

Ya think??

[Directed towards the ANALysts, not you drbio]